Sonomind
Sonomind45About
What does Sonomind do?
Sonomind provides a non-invasive, rapid, and effective therapeutic treatment for depression using ultrasound neuromodulation. Based on 25 years of research, their technology precisely targets deep brain regions involved in depression, offering a new approach for patients who do not respond to conventional treatments. Sonomind serves individuals suffering from depression, as well as psychiatrists and investors interested in advancing mental health solutions.
What is Sonomind's revenue?
StartupHub estimates Sonomind's annual revenue at $809K (range $333K to $956K, 27% confidence), based on comparable companies in the sector.
What is Sonomind's valuation?
StartupHub estimates Sonomind's effective valuation at $11.9M (range $8.1M to $19.4M, 19% confidence), based on comparable companies in the sector.
How much funding has Sonomind raised?
Sonomind has raised a total of $3M in funding.
Where is Sonomind headquartered?
Sonomind is headquartered in Tel Aviv, Israel.
When was Sonomind founded?
Sonomind was founded in 2021.
What industry does Sonomind operate in?
Sonomind operates in Mental Health Tech, HealthTech, AI Tool, Conversational AI, Voice AI, Personalized Wellness.
How many employees does Sonomind have?
Sonomind has approximately 14 people on record.
No comments yet. Be the first to share your take.